The authors acknowledge the contributions of numerous people who enabled us to complete this study in the midst of the tremendous effort to vaccinate as many of our patients as possible, as quickly as possible, during the COVID-19 pandemic. Staff throughout Fox Chase Cancer Center volunteered countless hours caring for our patients and contributing to this study. We thank the staff and volunteers of the Fox Chase COVID Vaccine Clinic, the Office of Clinical Research, the Lewis Katz School of Medicine at Temple University, the Volunteer Services Office, and the Cancer Prevention and Control Program Staff. We specifically thank the following people for their contributions to this project: Eileen Rall, AuD; Krisha Howell, MD; Sameera Kumar, MD; Chase Hansen, MD, MBA; Jonathan Paly, DO; Marc Smaldone, MD, MS; Jennifer Higa, MD; Elizabeth Bourne, MD; Kristen Manley, MD; Alan Haber, MD; Usman Ali, MD; Kaitlyn Gregory; Max Lefton; Jason Castellanos, MD, MS; Elizabeth Allen; Hailan Liu; Stephan Donnelly; Marcel Knotek; Lisa Bealin; Nicole Ventriglia; Yana Chertok; Sarah Schober; Maria Market; Tanu Singh, PhD; Aidan Rhodes Pearigen; Kayla Elizabeth Alderfer; Joshua Stewart; Emma Price; Emily Ren; Stan Taylor; Helen Gordon; Judith Maxwell; Judy Owens; Linda Wishner; Marcia Black; Tania Danker; Elizabeth Brown; Holly Kilpatrick; Karen Davis; April King; Denise Gibbs; Jennifer Reese, PhD; Lauren Zimmaro, PhD; Kristen Sorice; Folashade Adekunle; Andrew Belfiglio; Erin Tagai, PhD; Wanzi Yang; Yuku Chen; Colleen McKeown; Jessie Panick; Taylor Kazaoka; Minzi Li; and Julia Zhong.
Centers for Disease Control and Prevention. About the vaccine adverse event reporting system. Accessed November 22, 2021. Available at: https://wonder.cdc.gov/vaers.html
Centers for Disease Control and Prevention. Safety of COVID-19 vaccines. Accessed November 22, 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html
Desai A, Sachdeva S, Parekh T, et al. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 2020;6:557–559.
Gosain R, Abdou Y, Singh A, et al. COVID-19 and cancer: a comprehensive review. Curr Oncol Rep 2020;22:53.
Hwang JK, Zhang T, Wang AZ, et al. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks. J Hematol Oncol 2021;14:38.
Monin L, Laing AG, Muñoz-Ruiz M, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol 2021;22:765–778.
- Search Google Scholar
- Export Citation
, Monin L , Laing AG , Muñoz-Ruiz M Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol 2021; 22: 765– 778. 10.1016/S1470-2045(21)00213-8 33930323
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335–337.
Fanciullino R, Ciccolini J, Milano G. COVID-19 vaccine race: watch your step for cancer patients. Br J Cancer 2021;124:860–861.
Di Noia V, Renna D, Barberi V, et al. The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey. Eur J Cancer 2021;153:260–264.
- Search Google Scholar
- Export Citation
, Di Noia V , Renna D , Barberi V The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey. Eur J Cancer 2021; 153: 260– 264. 10.1016/j.ejca.2021.05.006 34183225
Waissengrin B, Agbarya A, Safadi E, et al. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors. Lancet Oncol 2021;22:581–583.
Ribas A, Sengupta R, Locke T, et al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov 2021;11:233–236.
Curigliano G, Eggermont AMM. Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen! Eur J Cancer 2021;153:257–259.